Consistently, high Bok and low TRIM28 levels correlate with increased survival in cancers like HCC and kidney cancer [139], further supporting Bok’s role as a tumor suppressor despite its pro-tumorigenic role in KRAS-driven lung cancer. This evidence concerns the gene KRAS and lung cancer.